Evidence map›Paper›PMID 35604432›Full record

ReviewMicrobial ecology2023

Bacillus spp. as Bio-factories for Antifungal Secondary Metabolites: Innovation Beyond Whole Organism Formulations.

Bruno Salazar, Aurelio Ortiz, Chetan Keswani, Tatiana Minkina, Saglara Mandzhieva, Satyendra Pratap Singh, Bhagwan Rekadwad, Rainer Borriss, Akansha Jain, Harikesh B Singh and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Microbial ecology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Soil-DerivedInternational journal of molecular sciences · 2026
    Article
  3. Journal of bacteriology · 2026
    Review
  4. Article
  5. Article
  6. Cyclic lipopeptides fromFrontiers in microbiology · 2026
    Article
  7. Frontiers in microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Antagonistic mechanism ofApplied and environmental microbiology · 2025
    Article
  12. Characterization of soil-derived Bacillus subtilis metabolites against breast cancer: In vitro and in silico studies.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Frontiers in cellular and infection microbiology · 2025
    Article
  18. Biocontrol effects ofFrontiers in microbiology · 2025
    Article
  19. Identification ofFrontiers in microbiology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Bruno SalazarFacultad De Ciencias Químicas, Benemérita Universidad Autónoma De Puebla, 72590, Puebla, Pue, México.
Aurelio OrtizFacultad De Ciencias Químicas, Benemérita Universidad Autónoma De Puebla, 72590, Puebla, Pue, México.
Chetan KeswaniAcademy of Biology and Biotechnology, Southern Federal University, Rostov-on-Don, 344006, Russia.ORCID http://orcid.org/0000-0002-2786-121X
Tatiana MinkinaAcademy of Biology and Biotechnology, Southern Federal University, Rostov-on-Don, 344006, Russia.
Saglara MandzhievaAcademy of Biology and Biotechnology, Southern Federal University, Rostov-on-Don, 344006, Russia.
Satyendra Pratap SinghDepartment of Mycology and Plant Pathology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, 221005, India.
Bhagwan RekadwadDivision of Microbiology and Biotechnology, Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, 575018, Karnataka, India.
Rainer BorrissInstitut Für Agrar- Und Gartenbauwissenschaften, Fachgebiet Phytomedizin, Humboldt-Universität Zu Berlin, Lentze-Allee 55-57, 14195, Berlin, Germany.
Akansha JainDivision of Plant Biology, Bose Institute, CIT Road, Kankurgachi, Kolkata, India.
Harikesh B SinghDepartment of Biotechnology, GLA University, Mathura, 281406, India.
Estibaliz SansineneaFacultad De Ciencias Químicas, Benemérita Universidad Autónoma De Puebla, 72590, Puebla, Pue, México. estisansi@yahoo.com.mx.ORCID http://orcid.org/0000-0002-1593-1890
Benemérita Universidad Autónoma de Puebla · MXSouthern Federal University · RUBanaras Hindu University · INBose Institute · INGLA University · INHumboldt-Universität zu Berlin · DEYenepoya University · IN

Funding

Ministry of Science and Higher Education of the Russian Federationt LabNOTs-21-01AB
6 · The paper itself

Abstract

Several fungi act as parasites for crops causing huge annual crop losses at both pre- and post-harvest stages. For years, chemical fungicides were the solution; however, their wide use has caused environmental contamination and human health problems. For this reason, the use of biofungicides has been in practice as a green solution against fungal phytopathogens. In the context of a more sustainable agriculture, microbial biofungicides have the largest share among the commercial biocontrol products that are available in the market. Precisely, the genus Bacillus has been largely studied for the management of plant pathogenic fungi because they offer a chemically diverse arsenal of antifungal secondary metabolites, which have spawned a heightened industrial engrossment of it as a biopesticide. In this sense, it is indispensable to know the wide arsenal that Bacillus genus has to apply these products for sustainable agriculture. Having this idea in our minds, in this review, secondary metabolites from Bacillus having antifungal activity are chemically and structurally described giving details of their action against several phytopathogens. Knowing the current status of Bacillus secreted antifungals is the base for the goal to apply these in agriculture and it is addressed in depth in the second part of this review.

Indexed as

Antifungal AgentsBacillusIndustrial MicrobiologyPest Control, BiologicalPlant DiseasesAgricultureCrops, AgriculturalFungicides, IndustrialHumansMultigene FamilyAntifungal AgentsFungicides, IndustrialAntifungalsBacillusBiofungicidesCrop protectionPhytopathogens

Identifiers

PMID35604432
OpenAlexW4281294819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.